Auditory Attention Decay Noted Post-Treatment in Pediatric Cerebellar Tumors
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
Apr 17
FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Apr 10
Trial Shows Targeted Treatment for Childhood Brain Tumor is Safe
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...
Apr 7
Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts caution that...
Mar 24
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh...
Mar 21
New therapeutic approach shows promise for pediatric high-grade gliomas
Paediatric high-grade gliomas (pHGG) in particular are a mostly fatal disease group with a median survival time of less than 18 months...
Mar 18
New test identifies high-risk childhood brain tumours, improving treatment decisions
Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common type of...
Mar 13
Exposure to CT radiation increases risk for childhood brain tumors
Exposure to radiation from head or neck CT imaging increased risk for childhood brain tumors , according to results of a nationwide...
Feb 11
Research discovery halts childhood brain tumor before it forms
Scientists at The Hospital for Sick Children (SickKids) have discovered a way to stop tumor growth before it starts for a subtype of...
Feb 7
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
Research out of Emory University and QIMR Berghofer Medical Research Institute in Queensland, Australia, has shown that a potential new...
Feb 5